Delivery Order SPE2DB22D3011-SPE2DB25FP8LY

Award Date 1/7/25
Potential Completion Date 1/8/25
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Cosentyx, a pharmaceutical medication, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $9,331.11 and is a firm fixed-price delivery order that runs through January 17, 2024. This award is part of a broader Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award is for the delivery of Cosentyx, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,945.89 and a completion date of May 6, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
This federal contract award is for the delivery of Cosentyx, a specialty medication, to the Defense Logistics Agency (DLA). The contract, valued at $6,234.28, has a period of performance through January 28, 2025. It was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award is for the delivery of Cosentyx, a specialty medication, to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $8,872.15 and a completion date of January 11, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract is not designated as a...
This federal contract award is for the delivery of Cosentyx, a specialty medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $13,050.87, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for...
This federal contract award is for the delivery of Cosentyx, a specialty medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $9,820.02, is a firm fixed-price delivery order with an ultimate completion date of January 7, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of Cosentyx, a prescription medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $4,565.85 and a completion date of July 3, 2024. The prime contractor is Amerisourcebergen Drug Corp, a large pharmaceutical distribution company that holds a significant Indefinite Delivery Contract (IDC) with the DLA valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for...
This federal contract award is for the delivery of Cosentyx, a 300mg dosage medication, to the Defense Logistics Agency (DLA). The $26,345.88 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary...
This federal contract award is for the delivery of Cosentyx, a specialty pharmaceutical medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $9,131.70, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. This is a delivery order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a comprehensive...
This federal contract award is for the delivery of Cosentyx medication doses to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, and has a ceiling value of $4,565.85. The contract is a delivery order with a firm fixed price and has an ultimate completion date of November 1, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB25FP8LY
    Delivery Order

This federal contract award is for the delivery of Cosentyx, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $13,845.38 and is a firm fixed price delivery order that runs through January 8, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/8/25, 9:52 AM